NewAmsterdam Pharma Co N.V.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $22.5 | $45.6 | $14.1 | $102.7 | — |
| Operating income | -$225.7 | -$176.3 | -$183.0 | -$3.6 | -$35.0 |
| Net income | -$203.8 | -$241.6 | -$176.9 | -$22.6 | -$41.8 |
| Cash Flow Statement | |||||
| Free cash flow | -$148.0 | -$159.2 | -$141.2 | $10.4 | -$29.5 |
Shares outstanding 119.5M · Free float 57.8%
Annual filing data through FY ended December 31, 2025; float as of October 6, 2026.